Benzinga | Nov 5, 2020 05:27PM EST

Global Blood Therapeutics Earlier Reported Q3 EPS $(0.97) Misses $(0.73) Estimate, Sales $36.89M Miss $43.98M Estimate

Global Blood Therapeutics (NASDAQ:GBT) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.73) by 32.88 percent. This is a 9.35 percent increase over losses of $(1.07) per share from the same period last year. The company reported quarterly sales of $36.89 million which missed the analyst consensus estimate of $43.98 million by 16.12 percent.